Page 167 - Programme book for The International Liver Congress 2015, EASL ILC 2015

YI P0271 EFFECTS OF FXR AGONIST PX20606 ON TUMOUR ePOSTERS
YI P0272 FORMATION IN ANIMAL MODELS OF NON-ALCOHOLIC
FATTY LIVER DISEASE
YI P0273 Anna Whitehead*, Gillian L. Patman, Ulrich Deuschle,
YI P0274 Christopher P. Day, Claus Kremoser, Dina G. Tiniakos,
YI P0275 Quentin M. Anstee, Helen L. Reeves, The United Kingdom
YI P0276
LONG-TERM INHIBITION OF EGFR IN HUMAN
CHOLANGIOCARCINOMA CELLS LEADS TO THE
INDUCTION OF AN EPITHELIAL TO MESENCHYMAL
TRANSITION PROGRAM AND ACTIVATION OF INSULIN/
INSULIN GROWTH FACTOR 1 RECEPTORS
Javier Vaquero*, Audrey Clapéron, Martine Mergey, Christèle Desbois-
Mouthon, Françoise Praz, Laura Fouassier, France

ISCHEMIC PRECONDITIONING OF INJURED STEATOTIC
LIVERS REDUCES HEPATOCELLULAR CARCINOMA
RECURRENCE
Lorenzo A. Orci*, Stéphanie Lacotte, Claudio De Vito, Graziano Oldani,
Philippe Morel, Lindsey Crowe, Christian Toso, Switzerland

LIVER TUMOR INCIDENCE IS DEPENDENT ON SEX AND
TELOMERASE STATUS IN TRP53 KNOCKOUT MICE
Michael Svinarenko*, Sarah-Fee Katz, Thomas Seufferlein,
Peter Schirmacher, Andrè Lechel, Germany

PDGFRA-MEDIATED LAMININ B1 DEPOSITION INDUCES
INVASION IN HUMAN HEPATOCELLULAR CARCINOMA
Olivier Govaere*, Michaela Petz, Jasper Wouters,Yves-Paul Vandewynckel,
An Ceulemans, Baki Topal, Chris Verslype, Hans Van Vlierberghe,
Frederik Nevens, Wolfgang Mikulits, Tania Roskams, Belgium

HIF2-ALPHA NEDDYLATION AS A SELECTIVE SERPINB3-
DEPENDENT MECHANISM LEADING TO ITS INCREASED
Stefania Cannito*, Gianmarco Villano, Cristian Turato,
Elisabetta Morello, Claudia Paternostro, Santina Quarta,
Sebastiano Colombatto, Fernando Lopitz-Otsoa, Maria Luz Martinez-
Chantar, Patrizia Pontisso, Maurizio Parola, Italy

Vienna, Austria • April 22–26, 2015 167